Join to View Full Profile
12902 Magnolia DriveTampa, FL 33612
Phone+1 813-745-4167
Fax+1 813-745-6817
Dr. Brayer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 2011 - 2015- University of South Florida MorsaniResidency, Internal Medicine, 2009 - 2011
- University of South Florida College of MedicineClass of 2009
H. Lee Moffitt Cancer Center and Research InstitutePost-Doctoral Fellowship, 2002 - 2005
La Jolla Institute for Allergy and ImmunologyPost-Doctoral Fellowship, 2000 - 2002
Certifications & Licensure
FL State Medical License 2011 - 2023
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase 1/2 Study of REGN5458 in Adult Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2019 Jan 23
Roles: Contact
Publications & Presentations
PubMed
- The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma.Praneeth Reddy Sudalagunta, Rafael R Canevarolo, Mark B Meads, Maria Silva, Xiaohong Zhao
Cancer Research. 2025-01-15 - 7 citationsSurvivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma.Ciara L Freeman, Reginald Atkins, Indumathy Varadarajan, Meghan Menges, Jeffrey Edelman
Clinical Cancer Research. 2023-11-14 - 12 citationsCardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma.Dae Hyun Lee, Abhishek Kumar, Turab Mohammed, Lauren C Peres, Melissa Alsina
Blood Advances. 2023-08-22
Abstracts/Posters
- Panobinostat As a Maintenance Therapy after Autologous Hematopoietic Cell Transplantation for Patients with Multiple MyelomaJason B. Brayer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Composition of Immune Subpopulations Influence Multiple Myeloma Disease ProgressionJason B. Brayer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Elotuzumab in Combination with an Immunomodulatory Agent (IMID) in Patients with Multiple Myeloma Refractory to Imids and/or Daratumumab: A Single-Institution Analysis...Jason B. Brayer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Society for Immunotherapy of CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
